levodopa has been researched along with Supranuclear Palsy, Progressive in 75 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.67) | 18.7374 |
1990's | 23 (30.67) | 18.2507 |
2000's | 20 (26.67) | 29.6817 |
2010's | 20 (26.67) | 24.3611 |
2020's | 10 (13.33) | 2.80 |
Authors | Studies |
---|---|
Borsek, M; Jeleňová, B; Necpál, J | 1 |
Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL | 1 |
Adachi, T; Hanajima, R; Hasegawa, M; Sakata, R; Sakuwa, M; Suzuki, Y; Takigawa, H | 1 |
Arai, H; Kunitoki, K; Mutoh, T; Taki, Y | 1 |
Galazky, I; Heinze, HJ; Hinrichs, H; Kupsch, A; Neumann, J; Sweeney-Reed, CM; Voges, J; Zaehle, T | 1 |
Park, JE | 1 |
Ishida, C; Kato-Motozaki, Y; Komai, K; Tagami, A; Takahashi, K | 1 |
Cairns, NJ; Criswell, S; Davis, AA; Hartlein, J; Kotzbauer, PT; Maiti, B; Martin, WRW; Miles, M; Norris, SA; Perlmutter, JS; Perrin, RJ; Racette, BA; Ushe, M; Zhong, Q | 1 |
Blinova, NM; Derevyanko, HP; Safin, SM | 1 |
Ju, H; Kwon, KY; Lee, EJ; Lee, M | 1 |
Bril, EV; Fedorova, NV; Kulua, TK; Mikhaylova, AD | 1 |
Avenali, M; De Icco, R; Fresia, M; Pacchetti, C; Perrotta, A; Sandrini, G; Serrao, M; Tassorelli, C | 1 |
Ali, F; Josephs, KA | 1 |
Gulmez Sevim, D; Gultekin, M; Karaca, C; Mirza, GE; Mirza, M; Unlu, M | 1 |
Buhmann, C; Hauptmann, B; Modreanu, R; Özdemir, G | 1 |
Buhmann, C; Jost, WH; Kassubek, J; Lingor, P; Schrag, A; Schwarz, J; Tönges, L | 1 |
Greene, P | 1 |
Aoki, M; Hasegawa, T; Kaneko, K; Kikuchi, A; Takeda, A; Tano, O | 1 |
Bergquist, F; Eklund, M; Holmberg, B; Thorlin, T; Zackrisson, T | 1 |
Hagiwara, M; Kasahata, N; Kato, H; Nakamura, A; Uchihara, T | 1 |
Bhidayasiri, R; Boonrod, N; Jitkritsadakul, O; Rerknimitr, R | 1 |
Ben M' Barek, L; Di Ruscio, P; Onofrj, M; Thomas, A; Varanese, S | 1 |
Pradhan, S; Tandon, R | 1 |
Algom, AA; Dickson, DW; Fujioka, S; Murray, ME; Rademakers, R; Ross, OA; Sanchez-Contreras, MY; Tacik, P; Tsuboi, Y; Uitti, RJ; Van Gerpen, JA; Wszolek, ZK | 1 |
Aguiar, PM; Barsottini, OG; Borges, V; Felício, AC; Ferraz, HB; Godeiro-Junior, C; Silva, SM | 1 |
Compta, Y; Ezquerra, M; Martí, MJ; Rey, MJ | 1 |
Kapsoritakis, AN; Kardasi, M; Manolakis, AC; Potamianos, SP; Psychos, AK; Tsiopoulos, FD | 1 |
Dziewas, R; Hamacher, C; Lohmann, H; Oelenberg, S; Ringelstein, EB; Teismann, I; Warnecke, T | 1 |
Tison, F | 1 |
Ben-Djebara, M; Gargouri, A; Gouider, R; Kacem, I | 1 |
Brown, P; Day, BL; Lees, AJ; Ling, H; Massey, LA | 1 |
Gawel, D; Gawel, M; Jamrozik, Z; Kaminska, A; Rowińska-Marcińska, K; Slawek, J; Szmidt-Salkowska, E | 1 |
Choe, GY; Choi, YL; Jeon, BS; Kim, JM; Lee, KH | 1 |
Birdi, S; Donat, JR; Fenton, M; George, D; Macaulay, R; Rajput, AH; Robinson, C; Rozdilsky, B | 1 |
Aniello, MS; De Mari, M; Defazio, G; Lamberti, P; Zenzola, A | 1 |
Chan, LL; Tan, EK; Wong, MC | 1 |
Rajput, A; Rajput, AH; Robinson, CA | 1 |
Drozdowski, W; Halicka, D; Kułakowska, A; Pogorzelski, R; Pyd, E | 1 |
Benecke, R; Classen, J; Grossmann, A; Kunesch, E; Wolters, A | 1 |
al-Din, AS; Hadeed, A; Lees, AJ; Williams, DR; Wreikat, AL | 1 |
Lang, AE | 1 |
Pavanni, R; Tan, EK; Tong, J; Wong, MC; Zhao, Y | 1 |
Bergmann, KJ; Salak, VL | 1 |
Halliday, GM; Hardman, CD; Karaconji, T; Murphy, KE | 1 |
Brown, P; Doyle, LM; Lees, AJ; Williams, DR | 1 |
Duvoisin, RC; Mark, MH; Miller, DC; Sage, JI; Walters, AS | 1 |
Boonen, S; Celen, H; Dom, R; Pelemans, W | 1 |
Fukuuchi, Y; Kobari, M; Nogawa, S; Obara, K; Shinohara, T | 1 |
Playford, ED | 1 |
Imai, H | 1 |
Fénelon, G; Feve, A; Guillard, A; Mahieux, F; Romatet, S | 1 |
Golbe, LI; Nieforth, KA | 1 |
Imai, H; Kondo, T; Nakamura, T; Narabayashi, H | 1 |
Chaudhuri, KR; D'Olhaberriague, L; Jellinger, K; Litvan, I; Mangone, CA; McKee, A; Parsa, A; Pearce, RK; Verny, M | 1 |
Campbell, G; Chaudhuri, KR; D'Olhaberriague, L; Jellinger, K; Litvan, I; Mangone, CA; McKee, A; Pearce, RK; Verny, M | 1 |
Almeida, OP; Tamai, S | 1 |
Mizuno, Y; Yanagisawa, N | 1 |
De Mari, M; Federico, F; Giannini, P; Iliceto, G; Lamberti, P; Lucivero, V; Mezzapesa, DM; Simone, IL; Tarantino, A | 1 |
Nishimiya, J; Yuasa, T | 1 |
Bentivoglio, AR; Daniele, A; Moro, E | 1 |
Calmes, J; Hendersen, N; Jankovic, J; Olson, S; Ondo, W; Overby, A; Warrior, D | 1 |
Ağan, K; Aktan, S; Gunal, DI | 1 |
Eriksson, B; Holmberg, B; Ingvarsson, P; Johnels, B; Rosengren, L | 1 |
Ferrarini, M; Filippini, G; Girotti, F; Monza, D; Soliveri, P; Testa, D | 1 |
Dubas, F; Henin, D; Vidailhet, M | 1 |
Fukuuchi, Y; Kobari, M; Nogawa, S; Shinohara, T; Takahashi, K | 1 |
Calne, DB; Cooper, S; Cordes, M; Morrison, S; Schofield, P; Snow, BJ; Sossi, V; Takahashi, H | 1 |
Bannister, R; Brooks, DJ; Frackowiak, RS; Ibanez, V; Lees, AJ; Marsden, CD; Mathias, CJ; Playford, ED; Quinn, N; Sawle, GV | 1 |
Abbott, RJ; D'Costa, DF; Millac, PA; Pye, IF | 1 |
Ahlskog, JE; Fealey, RD; Low, PA; Sandroni, P | 1 |
Agid, Y; Holemans, S; Javoy, F; Laterre, EC; Maloteaux, JM | 1 |
Chung, MY; Lan, C | 1 |
Sandyk, R | 1 |
Homma, Y; Ikuta, F; Takahashi, H; Takeda, S | 1 |
10 review(s) available for levodopa and Supranuclear Palsy, Progressive
Article | Year |
---|---|
"Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
Topics: Humans; Levodopa; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive; Systematic Reviews as Topic | 2021 |
[Progressive supranuclear palsy].
Topics: Humans; Levodopa; Middle Aged; Neurodegenerative Diseases; Neuroimaging; Parkinson Disease; Supranuclear Palsy, Progressive | 2021 |
Dyskinesia in multiple system atrophy and progressive supranuclear palsy.
Topics: Diagnosis, Differential; Dyskinesia, Drug-Induced; Dyskinesias; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive | 2019 |
Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy.
Topics: Aged; Basal Ganglia Diseases; Diagnosis, Differential; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Supranuclear Palsy, Progressive | 2019 |
["Red flags": when to be alerted and how to explore?].
Topics: Antiparkinson Agents; Basal Ganglia Diseases; Biomarkers; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive | 2010 |
Clinical and single-photon emission computed tomography study of pure akinesia with freezing of gait.
Topics: Diagnosis, Differential; Dopamine Agents; Gait Apraxia; Humans; Levodopa; Male; Middle Aged; Morocco; Speech Disorders; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2012 |
Positron emission tomography: applications to the investigation of movement disorders.
Topics: Cerebrovascular Circulation; Humans; Levodopa; Movement; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1994 |
[Festination and freezing].
Topics: Gait; Humans; Levodopa; Movement Disorders; Supranuclear Palsy, Progressive | 1993 |
[Progressive supranuclear palsy (PSP)].
Topics: Diagnosis, Differential; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Prognosis; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1999 |
[Parkinson disease: diagnostic and therapeutic criteria].
Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus | 2001 |
3 trial(s) available for levodopa and Supranuclear Palsy, Progressive
Article | Year |
---|---|
Compassionate trial of levodopa carbidopa intestinal gel infusion in two patients with progressive supranuclear palsy.
Topics: Aged; Antiparkinson Agents; Carbidopa; Compassionate Use Trials; Female; Gels; Humans; Levodopa; Male; Parkinson Disease; Supranuclear Palsy, Progressive; Treatment Outcome | 2014 |
Zolpidem in progressive supranuclear palsy.
Topics: Cross-Over Studies; Humans; Hypnotics and Sedatives; Levodopa; Male; Middle Aged; Pilot Projects; Pyridines; Supranuclear Palsy, Progressive; Zolpidem | 1999 |
CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antiparkinson Agents; Diagnosis, Differential; Discriminant Analysis; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Neurofilament Proteins; Parkinsonian Disorders; Spinal Puncture; Supranuclear Palsy, Progressive | 2001 |
62 other study(ies) available for levodopa and Supranuclear Palsy, Progressive
Article | Year |
---|---|
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2022 |
An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes.
Topics: Aged; Aged, 80 and over; Atrophy; Autopsy; Humans; Levodopa; Male; Neurodegenerative Diseases; Personality; Supranuclear Palsy, Progressive; tau Proteins | 2022 |
Adverse motor effects of progressive supranuclear palsy with frontal lobe signs: A case report.
Topics: Donepezil; Female; Frontal Lobe; Humans; Levodopa; Middle Aged; Single Photon Emission Computed Tomography Computed Tomography; Supranuclear Palsy, Progressive | 2019 |
Neuronal oscillations of the pedunculopontine nucleus in progressive supranuclear palsy: Influence of levodopa and movement.
Topics: Aged; Antiparkinson Agents; Brain Waves; Female; Humans; Levodopa; Male; Movement; Pedunculopontine Tegmental Nucleus; Supranuclear Palsy, Progressive | 2020 |
Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy.
Topics: Aged, 80 and over; Dopamine Agents; Female; Humans; Levodopa; Supranuclear Palsy, Progressive | 2020 |
Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features.
Topics: Diagnosis, Differential; Humans; Levodopa; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Putamen; Supranuclear Palsy, Progressive | 2021 |
Is Levodopa Response a Valid Indicator of Parkinson's Disease?
Topics: Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2021 |
[Progressive supranuclear paralysis with levodopa-induced dyskinesia].
Topics: Aged; Dyskinesias; Humans; Levodopa; Movement Disorders; Neurodegenerative Diseases; Supranuclear Palsy, Progressive | 2021 |
Early suspicion of progressive supranuclear palsy using dopamine transporter imaging: an illustrative case presenting with levodopa-responsive parkinsonism.
Topics: Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2021 |
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study.
Topics: Aged; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Pain; Pain Measurement; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2017 |
Corticobasal degeneration: key emerging issues.
Topics: Aniline Compounds; Basal Ganglia; Carbolines; Cerebral Cortex; Dopamine Agents; History, 20th Century; Humans; Levodopa; Neurodegenerative Diseases; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Thiazoles | 2018 |
Evaluation of Retinal Changes in Progressive Supranuclear Palsy and Parkinson Disease.
Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Nerve Fibers; Non-Randomized Controlled Trials as Topic; Optic Disk; Parkinson Disease; Prospective Studies; Retinal Diseases; Retinal Ganglion Cells; Supranuclear Palsy, Progressive; Tomography, Optical Coherence | 2018 |
Levodopa-induced dystonia in a patient with possible progressive supranuclear palsy with progressive gait freezing.
Topics: Aged; Diagnosis, Differential; Dopamine Agents; Dystonia; Female; Gait Disorders, Neurologic; Humans; Levodopa; Supranuclear Palsy, Progressive | 2018 |
[Dopaminergic drug-induced jaw-opening dystonia in a patient with progressive supranuclear palsy].
Topics: Aged; Dopamine Agents; Dystonia; Humans; Levodopa; Male; Mandibular Diseases; Supranuclear Palsy, Progressive | 2013 |
The discriminating properties of an optoelectronic movement analysis method in patients with parkinsonism.
Topics: Aged; Antiparkinson Agents; Diagnosis, Differential; Female; Humans; Levodopa; Linear Models; Logistic Models; Male; Middle Aged; Movement; Multiple System Atrophy; Parkinsonian Disorders; Posture; Reproducibility of Results; ROC Curve; Supranuclear Palsy, Progressive | 2013 |
An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies.
Topics: Aged, 80 and over; Alzheimer Disease; Amphetamine; Dementia; Humans; Imaging, Three-Dimensional; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2014 |
Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy.
Topics: Age of Onset; Aged; Deglutition; Deglutition Disorders; Dopamine Agents; Female; Humans; Levodopa; Male; Supranuclear Palsy, Progressive | 2014 |
Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation.
Topics: Accidental Falls; Aged; Antiparkinson Agents; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Humans; India; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Practice Guidelines as Topic; Prevalence; Supranuclear Palsy, Progressive | 2015 |
Tremor in progressive supranuclear palsy.
Topics: Aged; Carbidopa; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Retrospective Studies; Supranuclear Palsy, Progressive; Tremor | 2016 |
Clinical features of dystonia in atypical parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Cerebral Cortex; Dystonia; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2008 |
Parkinsonism, dysautonomia, REM behaviour disorder and visual hallucinations mimicking synucleinopathy in a patient with progressive supranuclear palsy.
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Brain; Fatal Outcome; Female; Hallucinations; Humans; Levodopa; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive; Synucleins; tau Proteins | 2009 |
Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) with fatal outcome, after the manifestation of an ampullary adenocarcinoma.
Topics: Adenocarcinoma; Aged; Amantadine; Ampulla of Vater; Antiparkinson Agents; Common Bile Duct Neoplasms; Fatal Outcome; Female; Humans; Indoles; Levodopa; Supranuclear Palsy, Progressive | 2010 |
Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.
Topics: Aged; Antiparkinson Agents; Deglutition Disorders; Endoscopy; Female; Humans; Levodopa; Male; Middle Aged; Statistics as Topic; Statistics, Nonparametric; Supranuclear Palsy, Progressive | 2010 |
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.
Topics: Aged; Analysis of Variance; Biomechanical Phenomena; Case-Control Studies; Cognition; Disease Progression; Dopamine Agents; Female; Fingers; Handwriting; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance; Supranuclear Palsy, Progressive | 2012 |
Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy.
Topics: Action Potentials; Aged; Aging; Antiparkinson Agents; Electrodiagnosis; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Motor Neuron Disease; Motor Neurons; Muscle, Skeletal; Neural Conduction; Peripheral Nerves; Supranuclear Palsy, Progressive | 2013 |
Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.
Topics: Antiparkinson Agents; Brain; Culture Techniques; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Humans; Levodopa; Middle Aged; Neurofibrillary Tangles; Supranuclear Palsy, Progressive | 2002 |
Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases.
Topics: Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Prognosis; Supranuclear Palsy, Progressive; Treatment Outcome | 2002 |
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Apomorphine; Apraxias; Blepharospasm; Dystonia; Eyelids; Female; Humans; Italy; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2002 |
Levodopa-induced oromandibular dystonia in progressive supranuclear palsy.
Topics: Aged; Antiparkinson Agents; Dystonia; Humans; Levodopa; Male; Mandible; Mouth; Supranuclear Palsy, Progressive | 2003 |
Essential tremor course and disability: A clinicopathologic study of 20 cases.
Topics: Adrenergic beta-Antagonists; Age of Onset; Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Essential Tremor; Female; Humans; Levodopa; Lewy Body Disease; Male; Propranolol; Saskatchewan; Supranuclear Palsy, Progressive | 2004 |
[Cognitive deficits in progressive supranuclear palsy].
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Female; Humans; Levodopa; Middle Aged; Neuropsychological Tests; Supranuclear Palsy, Progressive | 2003 |
Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes.
Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Corpus Callosum; Diagnosis, Differential; Electromyography; Humans; Levodopa; Magnetic Resonance Imaging; Magnetoencephalography; Middle Aged; Motor Cortex; Multiple System Atrophy; Muscle, Skeletal; Nerve Degeneration; Nerve Net; Neural Inhibition; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2004 |
Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia.
Topics: Adolescent; Adult; Age of Onset; Antiparkinson Agents; Child; Chromosomes, Human, Pair 1; Dementia; Female; Functional Laterality; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Pedigree; Pyramidal Tracts; Severity of Illness Index; Supranuclear Palsy, Progressive | 2005 |
Treatment of progressive supranuclear palsy and corticobasal degeneration.
Topics: Amantadine; Cerebral Cortex; Cholinesterase Inhibitors; Corpus Striatum; Donepezil; Dopamine Agents; Dopamine Agonists; Dystonia; Globus Pallidus; Humans; Indans; Levodopa; Nerve Degeneration; Piperidines; Substantia Nigra; Supranuclear Palsy, Progressive | 2005 |
Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism.
Topics: Adult; Antiparkinson Agents; Ataxin-3; Ataxins; Cross-Sectional Studies; Diagnosis, Differential; DNA Mutational Analysis; Drug Resistance; Essential Tremor; Female; Genetic Testing; Genotype; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Multiple System Atrophy; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins; Parkinsonian Disorders; Phenotype; Polymerase Chain Reaction; Repressor Proteins; Spinocerebellar Ataxias; Supranuclear Palsy, Progressive; Trinucleotide Repeat Expansion; Trinucleotide Repeats | 2007 |
Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive supranuclear palsy.
Topics: Deep Brain Stimulation; Dopamine Agents; Female; Humans; Levodopa; Longitudinal Studies; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Retrospective Studies; Subthalamic Nucleus; Supranuclear Palsy, Progressive; Time Factors | 2008 |
Excessive dopamine neuron loss in progressive supranuclear palsy.
Topics: Aged; Disease Progression; Dopamine; Dopamine Agonists; Female; Humans; Levodopa; Male; Nerve Degeneration; Neurons; Substantia Nigra; Supranuclear Palsy, Progressive | 2008 |
The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Auditory Pathways; Blinking; Brain Stem; Dementia; Diagnosis, Differential; Facial Muscles; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neck Muscles; Ocular Motility Disorders; Parkinsonian Disorders; Predictive Value of Tests; Reflex, Startle; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Tauopathies | 2008 |
Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.
Topics: Aged; Atrophy; Brain; Cerebral Arteries; Dementia, Multi-Infarct; Female; Humans; Intracranial Arteriosclerosis; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Supranuclear Palsy, Progressive | 1995 |
[Gait disorders and repeated falls in Steele-Richardson-Olszewski syndrome].
Topics: Accidental Falls; Aged; Cognition Disorders; Female; Gait; Humans; Levodopa; Magnetic Resonance Spectroscopy; Movement Disorders; Neurotransmitter Agents; Posture; Saccades; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed | 1995 |
Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.
Topics: Adult; Aged; Carbidopa; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed; Treatment Outcome; Xenon | 1995 |
[Parkinsonian features of Steele-Richardson-Olszewski syndrome].
Topics: Aged; Atrophy; Brain Stem; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed | 1993 |
Retrospective study of drug response in 87 patients with progressive supranuclear palsy.
Topics: Amitriptyline; Carbidopa; Humans; Imipramine; Levodopa; Retrospective Studies; Supranuclear Palsy, Progressive | 1993 |
Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
Topics: Benserazide; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Motor Activity; Movement Disorders; Neurologic Examination; Ocular Motility Disorders; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive | 1993 |
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Topics: Aged; Antiparkinson Agents; Deglutition Disorders; Diagnosis, Differential; Diagnostic Errors; Diet Therapy; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Medical Records; Middle Aged; Parkinson Disease; Pneumonia, Aspiration; Supranuclear Palsy, Progressive; Survival Rate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Topics: Fixation, Ocular; Gait; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive | 1997 |
Nortriptyline for the treatment of depression in progressive supranuclear palsy.
Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Dopamine Agents; Female; Fluoxetine; Humans; Levodopa; Nortriptyline; Remission Induction; Supranuclear Palsy, Progressive | 1997 |
Analyzer workshop on the treatment of Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Bromocriptine; Cerebrovascular Disorders; Computer Simulation; Diagnosis, Differential; Forecasting; Humans; Levodopa; Middle Aged; Parkinson Disease; Supranuclear Palsy, Progressive; Tablets | 1997 |
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
Topics: Aged; Antiparkinson Agents; Aspartic Acid; Atrophy; Cerebral Cortex; Choline; Corpus Striatum; Creatinine; Female; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Phosphocreatine; Protons; Putamen; Supranuclear Palsy, Progressive | 1997 |
Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
Topics: Aged; Antiparkinson Agents; Carbidopa; Case-Control Studies; Diagnosis, Computer-Assisted; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Postural Balance; Posture; Severity of Illness Index; Supranuclear Palsy, Progressive | 2000 |
A case of spontaneous arm levitation in progressive supranuclear palsy.
Topics: Aged; Arm; Dopamine Agents; Dyskinesias; Humans; Levodopa; Male; Supranuclear Palsy, Progressive; Treatment Failure | 2000 |
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
Topics: Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Female; Humans; Levodopa; Life Tables; Male; Middle Aged; Multiple System Atrophy; Supranuclear Palsy, Progressive | 2001 |
[A case at Salpêtrière hospital November 1990. Parkinson syndrome with poor response to dopa therapy in a 64 year-old man].
Topics: Atrophy; Corpus Striatum; Diagnosis, Differential; Drug Resistance; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease, Secondary; Substantia Nigra; Supranuclear Palsy, Progressive | 1992 |
Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease.
Topics: Aged; Brain; Cerebrovascular Circulation; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
[L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function].
Topics: Aged; Dopamine; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Topics: Adult; Aged; Caudate Nucleus; Corpus Striatum; Humans; Levodopa; Middle Aged; Nerve Degeneration; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine; Salicylamides; Substantia Nigra; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
The apomorphine test in parkinsonian syndromes.
Topics: Aged; Apomorphine; Diagnosis, Differential; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Muscular Atrophy; Neurologic Examination; Olivopontocerebellar Atrophies; Parkinson Disease; Parkinson Disease, Secondary; Prognosis; Supranuclear Palsy, Progressive | 1991 |
Autonomic involvement in extrapyramidal and cerebellar disorders.
Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Cerebellar Diseases; Cognition Disorders; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reflex; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Valsalva Maneuver | 1991 |
[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy.
Topics: Aged; Brain; Dizocilpine Maleate; Humans; Kinetics; Levodopa; Organ Specificity; Parkinson Disease; Receptors, N-Methyl-D-Aspartate; Reference Values; Supranuclear Palsy, Progressive | 1991 |
[Progressive supranuclear palsy: clinical report on 7 cases and review of literature].
Topics: Aged; Electronystagmography; Female; Humans; Levodopa; Male; Middle Aged; Supranuclear Palsy, Progressive; Theta Rhythm; Tomography, X-Ray Computed | 1990 |
Excessive yawning and progressive supranuclear palsy.
Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Middle Aged; Supranuclear Palsy, Progressive; Yawning | 1987 |
[An autopsy case of progressive supranuclear palsy showing "pure akinesia without rigidity and tremor and with no effect by L-dopa therapy (Imai)"].
Topics: Aged; Brain; Bulbar Palsy, Progressive; Diagnosis, Differential; Female; Humans; Levodopa; Limbic System; Ophthalmoplegia; Parkinson Disease; Supranuclear Palsy, Progressive | 1987 |